Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company, today announced the pricing of an underwritten public offering of 11,627,907 American Depositary Shares (“ADSs”), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback